Succeeding with world-class medicine

M1 Kliniken AG

Medical Care For a Better Life – with this vision M1 Kliniken AG, one of the fastest growing healthcare services providers in Germany, has developed an innovative concept, which offers affordable access to beauty treatments at highest qualitative standards.

M1 stock

ISIN: DE000A0STSQ8 | WKN: A0STSQ | Ticker symbol: M12

Title name: Bearer Share
Number of shares: 19.643.403
Stock exchange: Frankfurt, Stuttgart, Berlin, Düsseldorf, München, Hannover, Xetra, Hamburg, Tradegate Exchange
Market segment: Open Market
Designated Sponsoring: Kepler Cheuvreux
Inital trading day: 14.09.2015

More information

| Investor News

  • Group revenue rises to just under EUR 165 million (EUR 37 million in H1-
    2020)
  • Consolidated EBITDA amounts to EUR 9.9 million (previous year: EUR 1.7
    million); EBIT amounts to EUR 7.1 million (previous year: EUR -0.05
    million)
  • Beauty: Significant increase in treatment and sales figures; Coronarelated
    ‘idle capacity’ due to vaccination intervals

| Investor News

After the Corona-related restrictions of the previous year, the Management Board is confident about the development of the company in the current financial year and the future.

| Investor News

M1 Kliniken AG announces figures for the first quarter of 2021. According to these figures, the consolidated group revenue of the M1 Group in the first quarter of the financial year 2021 rose by approx. 250% year-on-year to just under EUR 81 million (previous year: EUR 23 million). Of this, HAEMATO AG (without M1 Aesthetics), which was not yet consolidated in the same period of the previous year, accounted for sales of a good EUR 59 million.

Contact

M1 Kliniken AG

Grünauer Straße 5
12557 Berlin
Germany

T. +49 (0) 30 347 47 44 14
F. +49 (0) 30 347 47 44 17

Contact us